31.03.2020
- Biopharmaceutical producer Gilead Sciences has surprised the market by asking the US Food and Drug Administration (FDA) to rescind the orphan drug status of its experimental...
05.10.2017
- UK pharmaceutical company Ergomed has acquired PSR Group, a Dutch contract research organization (CRO) that specializes in orphan drug development and is regarded as a leading...
18.06.2013
- ViroPharma is attracting preliminary interest from several pharmaceutical companies about buying the orphan drugmaker, according to three people familiar with the matter. While...
30.09.2011
- ViroPharma announced the license of worldwide rights from Intellect Neurosciences to its clinical stage drug candidate, OX1, being developed for the treatment of Friedreich's...
